These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20922813)

  • 1. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
    Fakhari A; Baoum A; Siahaan TJ; Le KB; Berkland C
    J Pharm Sci; 2011 Mar; 100(3):1045-56. PubMed ID: 20922813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
    Zhang N; Chittasupho C; Duangrat C; Siahaan TJ; Berkland C
    Bioconjug Chem; 2008 Jan; 19(1):145-52. PubMed ID: 17997512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells.
    Chittasupho C; Xie SX; Baoum A; Yakovleva T; Siahaan TJ; Berkland CJ
    Eur J Pharm Sci; 2009 May; 37(2):141-50. PubMed ID: 19429421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
    Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P
    Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
    Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S
    Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.
    Park J; Mattessich T; Jay SM; Agawu A; Saltzman WM; Fahmy TM
    J Control Release; 2011 Nov; 156(1):109-15. PubMed ID: 21723893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.
    Toti US; Guru BR; Grill AE; Panyam J
    Mol Pharm; 2010 Aug; 7(4):1108-17. PubMed ID: 20527782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
    Cai H; Liang Z; Huang W; Wen L; Chen G
    Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.
    Steinbach JM; Seo YE; Saltzman WM
    Acta Biomater; 2016 Jan; 30():49-61. PubMed ID: 26602822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermidine-mediated poly(lactic-
    Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
    Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Targeting of Poly Lactic-Co-Glycolic Acid Nanoparticles by Surface Functionalization with Peptides.
    de Oliveira TD; Travassos LR; Arruda DC; Tada DB
    J Biomed Nanotechnol; 2021 Jul; 17(7):1320-1329. PubMed ID: 34446135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.